• Blog
  • Allergy Diagnostics Market Analysis & Forecast | 2022-2028

    Allergy Diagnostics Market Analysis & Forecast | 2022-2028

    Allergy Diagnostics Market Analysis & Forecast | 2022-2028
    Report code - SRHL102 Delivery - 2 Weeks
    Allergy Diagnostics Market Size, Share, Trend, Forecast, Growth & Industry Analysis (2 See more...

    Insights

    The Global Allergy Diagnostics Market was estimated to grow from USD 4.96 Billion in 2021 to USD 10.33 Billion by 2028 at a healthy CAGR of 10.94% during the forecast period of 2022-2028.

    The new research study analyzes industry trends, pricing, patents, conference and webinar materials, key stakeholders, and buying behavior in the allergy diagnostics market.

    Allergy Diagnostics Market Size

    Want to know more about the market scope? Register Here.

    What are allergy diagnostics?

    Allergy diagnostics are performed to identify allergens like mold, bee stings, and peanuts, pet dander, which can cause allergies. An allergy is an immune system hypersensitivity disorder. Allergic reactions occur when a person's immune system reacts to harmless substances in the environment known as allergens.

    Global Allergy Diagnostics Market Highlights

    Market Size in 2021

    US$ 4.96 Billion

    Market Size in 2028

    US$ 10.33 Billion

    Market Growth by 2022-2028

    CAGR of 10.94%

    Base Year of Study

    2021

    Trend Period

    2016-2020

    Forecast Period

    2022-2028

    Dominant Region

    North America region accounted for the fastest-growing market share during the forecast period.

    Key Players

    Some of the key players in the global market are-

    • Danaher Corporation
    • Neogen Corporation
    • Eurofins Scientific
    • Euroimmun Medizinische Labordiagnostika AG
    • Hollister Stier Allergy
    • Minaris Medical America, Inc.
    • Romer Labs Division Holding GmbH
    • Siemens Healthineers AG
    • Stallergenes Greer Ltd.
    • Thermo Fisher Scientific.

    Market Drivers

    The global allergy diagnostics market is driven by several factors, including:

    • Rising prevalence of allergic diseases: Allergies are among the most common diseases, affecting around 1 in 5 people. Allergies like Asthma, food allergies, etc. are growing rapidly. According to various sources, more than 330 million people are suffering from Asthma, and 2,50,000 deaths are attributed to this each year. The estimates show that 100 million new asthma cases may be detected. This growing prevalence of different allergies heightens the demand for allergy diagnostics market.
    • Growing levels of environmental pollution – Air pollution remains one of the most common causes of allergies across the globe. Data from the World Health Organization shows that 9 out of 10 people inhale air containing high levels of pollution. This gives rise to different allergies and creates a need for diagnosis.
    • Increasing adoption of IVD techniques - In vitro diagnostics (IVD) techniques are gaining traction significantly propelling the allergy diagnostics market. IVD techniques are used to diagnose diseases and other conditions by analyzing samples of blood, urine, tissue, and other bodily fluids.
      Technological advancements – With the growing need for allergy diagnosis, more accurate, and less invasive methods of diagnosis are being developed. For instance, in June 2023, researchers from the Biological Science Research division at Kao Corporation developed a breakthrough ‘RNA monitoring’ method to diagnose early-onset atopic dermatitis in infants using sebum.

    Allergy Diagnostics Market Snapshot

    Want to know more about the market scope? Register Here.

    Segment Analysis

    By Product & Service Type

    The market is segmented into consumables, instruments, and services.

    The Consumables segment is expected to capture the major share of the global market during the forecast period. The growing prevalence of allergies and the need for rapid tests to diagnose allergic conditions can be attributed to the dominance of the consumables segment.

    Instruments accounted for the second-largest share of the global allergy diagnostics market in 2021, due to the introduction of technologically advanced products with improved accuracy and throughput. Increasing laboratory automation and healthcare improvements are expected to provide lucrative growth opportunities for this market.

    Companies' growing focus on R&D to develop novel diagnostic equipment, tests, and kits to address unmet medical needs has a significant impact on market growth.

    By Test Type

    The market is segmented into in vivo tests and in vitro tests.

    In Vivo Tests are estimated to hold the major share of the market during the forecast period. The growing demand for efficient, rapid, and simple testing options has fueled the growth of in vivo diagnostic tests, which measure the reactivity and susceptibility of dermal mast cells to indicate allergic sensitivity. These procedures involve skin exams with standardized allergenic extracts to ensure reliability.

    The in vitro tests segment is expected to grow significantly over the forecast period, as these tests are used to identify allergen-specific immunoglobulin E (IgE). Radioallergosorbent testing (RAST) is an in vitro method for detecting allergen-specific antibodies of a new immunoglobulin class called immunoglobulin D (IgD). The increasing prevalence of various allergic diseases is driving demand for early detection and diagnosis of allergens, which is expected to propel the market growth for efficient diagnostic tests and systems.

    By End-User Type

    The market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and other end-users.

    Diagnostic Laboratories are estimated to hold the major share of the global market during the forecast period. The diagnostic Laboratories segment is driven by the growing awareness among consumers regarding the management of allergic diseases, preference for proper diagnosis from specialists, and the availability of funds for the operation of independent diagnostic laboratories.

    By Region

    North America is estimated to be the dominating region in the global market over the forecast period.

    The region is dominating because of favorable regulations and initiatives by associations, increasing incidences of allergies, and favorable reimbursement conditions for allergy diagnosis, all of which are fuelling regional market growth. Furthermore, Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.

    Allergy Diagnostics Market Region

    Want to know which region offers the best growth opportunities? Register Here.

    The Asia Pacific region is projected to grow at the fastest CAGR over the forecast period, driven by key markets such as Japan, China, and India. Key players in these countries are undertaking various strategic initiatives to increase their dominance in the regional market.

    Segmentation

    This report studies the market covering 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The global allergy diagnostics market is segmented into the following categories.

    By Product & Service Type

    • Consumables
    • Instruments  
      • Regional Analysis: North America, Europe, Asia-Pacific, and RoW
      • Type Analysis: Immunoassay Analyzers, Elisa Analyzers, Luminometers, and Other Instruments
    • Services

    By Test Type

    • In Vivo Tests
      • Regional Analysis: North America, Europe, Asia-Pacific, and RoW
      • Type Analysis: Skin Prick Tests, Patch Tests, and Other In Vivo Tests
    • In Vitro Tests

    By Allergen Type

    • Inhaled Allergens
    • Food Allergens
    • Drug Allergens
    • Other Allergens

    By End-User Type

    • Diagnostic Laboratories
    • Hospital-based Laboratories
    • Academic Research Institutes
    • Other End-Users

    By Region

    • North America (Country: the USA, Canada, and Mexico) 
    • Europe (Country: Germany, France, the UK, Russia, and Rest of Europe)
    • Asia-Pacific (Country: China, Japan, India, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region: Latin America, the Middle East, and Others)

    Report Features

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

     

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the allergy diagnostics market.

    How lucrative is the future?

    The market forecast and trend data and emerging trends.

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts.

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast.

    What are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis.

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, and Life cycle analysis.

    What are the factors affecting the market?

    Drivers & challenges.

    Will I get the information on my specific requirements?

    10% free customization.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Target Audience

    The following is a list of the customers that the market aims to convert the most:

    • Manufacturers
    • Suppliers
    • Distributors
    • Organizations
    • Government bodies

    Critical Questions Answered in the Report

    • What are the key trends in the market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the market?
    • What are the key strategies adopted by the major vendors to lead in the market?
    • What is the market share of the top vendors?

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Allergy diagnostics are performed to identify allergens like mold, bee stings, and peanuts, pet dander, which can cause allergies. An allergy is an immune system hypersensitivity disorder. Allergic reactions occur when a person's immune system reacts to harmless substances in the environment known as allergens.

    The global allergy diagnostics market is expected to reach USD 10.33 Bn in 2028 from USD 4.96 Bn in 2021.

    The market is expected to grow at a CAGR of 10.94% during the forecast period.

    Some of the key players in the Allergy Diagnostics market are- Danaher Corporation, Eurofins Scientific, Euroimmun Medizinische Labordiagnostika AG, HollisterStier Allergy, Minaris Medical America, Inc., Neogen Corporation, Romer Labs Division Holding GmbH, Siemens Healthineers AG, Stallergenes Greer Ltd., Thermo Fisher Scientific.

    North America is estimated to be the largest region in the market owing to a growing percentage of the geriatric population in the regional market.

    The global allergy diagnostics market is driven by several factors, including: 1. Rising prevalence of allergic diseases: Allergies are among the most common diseases, affecting around 1 in 5 people. Allergies like Asthma, food allergies, etc. are growing rapidly. According to various sources, more than 330 million people are suffering from Asthma, and 2,50,000 deaths are attributed to this each year. The estimates show that 100 million new asthma cases may be detected. This growing prevalence of different allergies heightens the demand for allergy diagnostics market. 2. Growing levels of environmental pollution Air pollution remains one of the most common causes of allergies across the globe. Data from the World Health Organization shows that 9 out of 10 people inhale air containing high levels of pollution. This gives rise to different allergies and creates a need for diagnosis. 3. Increasing adoption of IVD techniques - In vitro diagnostics (IVD) techniques are gaining traction significantly propelling the allergy diagnostics market. IVD techniques are used to diagnose diseases and other conditions by analyzing samples of blood, urine, tissue, and other bodily fluids. 4. Technological advancements With the growing need for allergy diagnosis, more accurate, and less invasive methods of diagnosis are being developed. For instance, in June 2023, researchers from the Biological Science Research division at Kao Corporation developed a breakthrough RNA monitoring method to diagnose early-onset atopic dermatitis in infants using sebum.